This inventor holds 1 USPTO granted patent. Top assignee: Biovitrum Ab. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: Jan Hörling: Innovator in Medical Research
Introduction
Jan Hörling is a notable inventor based in Lidingö, Sweden. He has made significant contributions to the field of medical research, particularly in relation to obesity and diabetes. His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Jan Hörling holds a patent for "Promoter sequences." This invention pertains to an isolated human Site-1 Protease promoter region. The patent also includes screening methods for agents that decrease the expression of Site-1 protease. These agents have the potential to be useful in treating medical conditions related to obesity and diabetes. He has 1 patent to his name.
Career Highlights
Hörling has worked at Biovitrum AB, a company known for its focus on biotechnology and pharmaceutical development. His role at Biovitrum AB has allowed him to contribute to groundbreaking research and innovations in the medical field.
Collaborations
Throughout his career, Jan has collaborated with esteemed colleagues, including Margareta Forsgren and Lars Abrahmsén. These partnerships have enhanced his research and expanded the impact of his inventions.
Conclusion
Jan Hörling is a dedicated inventor whose work in medical research has the potential to improve the lives of many individuals suffering from obesity and diabetes. His contributions to the field are commendable and reflect his commitment to innovation.